Universe Pharmaceuticals INC
UPC
$4.91
-$0.21-4.10%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -32.61% | -55.89% | -69.59% | -28.25% | 24.67% |
| Total Depreciation and Amortization | -4.56% | -2.28% | 0.04% | -2.42% | -4.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.98% | 542.58% | 760.61% | 635.76% | 89.44% |
| Change in Net Operating Assets | -131.10% | -107.83% | -84.96% | -42.72% | 0.45% |
| Cash from Operations | -951.24% | -930.90% | -132.22% | -26.64% | 185.10% |
| Capital Expenditure | -456.11% | -331.16% | -188.08% | -17.55% | 52.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -717.19% | 87.88% | 97.11% | 98.00% | 98.87% |
| Total Debt Issued | 155.80% | 58.38% | 0.61% | -10.85% | -25.29% |
| Total Debt Repaid | 21.37% | -12.24% | -69.51% | -67.36% | -65.27% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,541.71% | 807.32% | -52.09% | -86.20% | -141.91% |
| Foreign Exchange rate Adjustments | 216.45% | -5.26% | -116.73% | 15.40% | 76.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,781.04% | 1,277.97% | -219.30% | -23.87% | 81.99% |